DocSym
β
Searchsearch
Search
(D68.3) Haemorrhagic disorder due to circulating anticoagulants
More details coming soon
734 830 in individuals diagnosis haemorrhagic disorder due to circulating anticoagulants confirmed
26 707 deaths with diagnosis haemorrhagic disorder due to circulating anticoagulants
4% mortality rate associated with the disease haemorrhagic disorder due to circulating anticoagulants
Diagnosis haemorrhagic disorder due to circulating anticoagulants is diagnosed Women are 9.01% more likely than Men
334 299
Men receive the diagnosis haemorrhagic disorder due to circulating anticoagulants
11 162 (3.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
400 531
Women receive the diagnosis haemorrhagic disorder due to circulating anticoagulants
15 545 (3.9 %)Died from this diagnosis.
Risk Group for the Disease haemorrhagic disorder due to circulating anticoagulants - Men aged 75-79 and Women aged 80-84
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features haemorrhagic disorder due to circulating anticoagulants
Absence or low individual and public risk
Haemorrhagic disorder due to circulating anticoagulants - what does this mean
Haemorrhagic disorder due to circulating anticoagulants occurs when anticoagulants, usually in the form of drugs or natural substances, interfere with the body's ability to form blood clots. this can lead to excessive bleeding, which can be life-threatening.
What happens during the disease - haemorrhagic disorder due to circulating anticoagulants
Haemorrhagic disorder due to circulating anticoagulants is caused by a deficiency or malfunction of the proteins responsible for clotting the blood, such as factor viii or factor ix. this leads to a decrease in the levels of these proteins, resulting in an inability to clot the blood and an increased risk of bleeding. additionally, the presence of anticoagulants in the blood can further increase the risk of bleeding by preventing the clotting proteins from working properly.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
14 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Haemorrhagic disorder due to circulating anticoagulants - Prevention
The best way to prevent haemorrhagic disorder due to circulating anticoagulants is to limit the use of anticoagulants to those who have an established medical need, and to monitor their use closely. additionally, it is important to ensure that patients are aware of the risks associated with anticoagulant use and to provide lifestyle advice to reduce the risk of bleeding.